Opposition ‘hedging bets’ with Pfizer amid AstraZeneca efficacy concerns
The federal government is being urged to reconsider the prominence of the AstraZeneca COVID-19 vaccine in Australia’s rollout plan.
The AstraZeneca vaccine has been found to have an efficacy of 62 per cent in clinical trials, too low to achieve herd immunity according to medical experts.
Labor leader Anthony Albanese told Chris Smith the findings reinforce the need to obtain significantly more doses of the more effective Pfizer vaccine.
“It’s why we’ve argued … that we should be hedging our bets, and should have six horses in the race rather than just a few.
“The impact of this, Chris, is not just a health impact, there’s the mental health impact [and] the economic impact as well.”
Click PLAY below to hear the full interview